Results 91 to 100 of about 17,280 (228)

Recommendations for The Conduct of Economic Evaluations in Osteoporosis: Outcomes of An Experts’ Consensus Meeting Organized by The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) And the US Branch of The International Osteoporosis Foundation [PDF]

, 2019
Summary Economic evaluations are increasingly used to assess the value of health interventions, but variable quality and heterogeneity limit the use of these evaluations by decision-makers.
Adachi, J.D., Al-Daghri, N., Bruyère, O., Bukata, S.V., Chandran, M., Cooper, C., Einhorn, T.A., Gold, D.T., Halbout, P., Harvey, N.C., Hiligsmann, M., Jiwa, F., Kanis, J.A., Kendler, D.L., Lewiecki, E.M., Messina, O.D., Osteoporosis Canada, Pinto, D., Reginster, J.-Y., Rizzoli, René, Saag, K.G., Si, L., Silverman, S., the Committee of Scientific Advisors and the Committee of National Societies of IOF, the Scientific Advisory Board of ESCEO, the US National Osteoporosis Foundation, Tosteson, A.N.A.   +26 more
core   +3 more sources

Biocompatible Mesoporous Materials for Bone Therapy

Advanced Science, Volume 12, Issue 39, October 20, 2025.
Biocompatible mesoporous materials (BMMs), characterized by high specific surface area, tunable pore size, different shapes and structures, and multidimensional functionalized modifications, have revolutionary applications in treating bone‐related diseases.
Biao Yu, Yan Wu, Yang Hong, Peng Wang, Xiaowen Liu, Yonghui Deng, Jiacan Su   +6 more
wiley   +1 more source

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review

São Paulo Medical Journal
CONTEXT AND OBJECTIVE: Osteoporosis is defined as a disease characterized by low bone mass and deterioration of the bone tissue microarchitecture. Teriparatide stimulates the formation and action of osteoblasts, which are responsible for bone formation ...
Virgínia Fernandes Moça Trevisani, Rachel Riera, Aline Mizusaki Imoto, Humberto Saconato, Álvaro Nagib Atallah   +4 more
doaj   +1 more source

Indications to teriparatide treatment in patients with osteoporosis. [PDF]

, 2011
To prevent osteoporotic fracture occurrence, a variety of treatment regimens with different mechanisms of action is available. The antiresorptive bisphosphonate drugs are currently the most commonly prescribed agents in the management of patients with ...
Kraenzlin, M., Krieg, M.A., Lamy, O., Lippuner, K., Mellinghoff, H.U., Rizzoli, R.   +5 more
core   +2 more sources

A randomized controlled trial of teriparatide for accelerating bone union and improving clinical outcomes in patients with pertrochanteric fracture fixation

Scientific Reports
This prospective, double-blind, placebo-controlled, randomized trial evaluated the effects of teriparatide following pertrochanteric fracture fixation on bone healing and clinical outcomes.
Chotetawan Tanavalee, Srihatach Ngarmukos, Chavarin Amarase, Saran Tantavisut, Nonn Jaruthien, Aree Tanavalee   +5 more
doaj   +1 more source

Short-Term Treatment With Teriparatide Restores Independent Ambulation in a Patient With Glucocorticoid-Induced Osteonecrosis of the Knees and Ankles [PDF]

, 2021
Xin Chen, Mizuho S. Mimoto
openalex   +1 more source

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis

Therapeutics and Clinical Risk Management, 2010
Arthur N Lau, Jonathan D AdachiDivision of Rheumatology and Department of Medicine, St Joseph’s Healthcare and McMaster University, Hamilton, Ontario, CanadaAbstract: Glucocorticoids are commonly used in various fields within medicine.
Arthur N Lau, Jonathan D Adachi
doaj  

No effect of teriparatide on migration in total knee replacement: A randomized controlled trial involving 50 patients

Acta Orthopaedica, 2017
Background and purpose — Aseptic loosening is a main cause of late revision in total knee replacement (TKR). Teriparatide, a recombinant parathyroid hormone (PTH), stimulates osteoblasts and has been suggested to improve cancellous bone healing in humans.
Håkan Ledin, Lars Good, Torsten Johansson, Per Aspenberg   +3 more
doaj   +1 more source

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

BMC Musculoskeletal Disorders, 2012
Background This paper presents the model and results to evaluate the use of teriparatide as a first-line treatment of severe postmenopausal osteoporosis (PMO) and Glucocorticoid-induced osteoporosis (GIOP).
Murphy Daniel R, Smolen Lee J, Klein Timothy M, Klein Robert W   +3 more
doaj   +1 more source

Using Teriparatide to Augment Healing in a Humeral Shaft Nonunion: A Case Report [PDF]

, 2023
Chaitanya S Puvvada, Jaithra S Marripaty
openalex   +1 more source